Thursday, September 3, 2026
spot_img

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.

Effective September 1, 2026, in connection with commencing employment as Chief Financial Officer, Michael Grasher was granted an award of restricted stock units covering 239,616 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and awards of performance stock units covering a target of 239,616 shares of Common Stock (for which up to 479,232 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health as to one-half of the underlying shares on the first anniversary of the grant date, with the remainder vesting in six substantially equal quarterly installments beginning on the 15-month anniversary of the grant date. The performance stock units provide a target number of shares of Common Stock that would be earned based on (i) Teladoc Health’s adjusted EBITDA for 2026 (“EBITDA PSUs”) and (ii) Teladoc Health’s actual compound annual revenue growth rate during 2026-2028 (“Revenue CAGR PSUs”). One-half of any earned EBITDA PSUs would vest on the first anniversary of the grant date and the remaining one-half would vest in six substantially equal quarterly installments beginning on the 15-month anniversary of the grant date. Any earned Revenue CAGR PSUs would vest on March 1, 2029.

The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.

About Teladoc Health

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at www.teladochealth.com.

Media:
Lou Serio
202-569-9715
[email protected]

Powered by SlickText.com

Hot this week

Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French

TVA Sports to broadcast up to 350 regular-season NHL...

Figure Technology Solutions to Participate in Upcoming Investor Conferences

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) --...

DBV Technologies to Participate in Upcoming September Investor Conferences

Châtillon, France, September 3, 2026 DBV Technologies to...

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem...

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE...

Topics

DBV Technologies to Participate in Upcoming September Investor Conferences

Châtillon, France, September 3, 2026 DBV Technologies to...

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem...

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE...

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial...

Root to Participate in Upcoming Investor Conferences

COLUMBUS, Ohio, Sept. 03, 2026 (GLOBE NEWSWIRE) --...
spot_img

Related Articles

Popular Categories

spot_img